Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2013

01-12-2013 | Clinical Image

Diltiazem-Associated Hyperpigmentation

Authors: Michelle Campbell, MD, Jesleen Ahluwalia, MD, Alice C. Watson, MD

Published in: Journal of General Internal Medicine | Issue 12/2013

Login to get access

Excerpt

A 59-year-old African American female presented with a one-year history of progressive skin darkening. Her only symptom was mild itching. Medications included diltiazem 180 mg daily (extended release), prescribed three years earlier. Examination revealed blue-gray reticular hyperpigmentation in a photodistributed pattern on the face, neck, “V of the chest,” and extensor forearms (Fig. 1a, b). Punch biopsy showed a predominantly lichenoid reaction with upper dermal melanophages.
Literature
1.
go back to reference Jaka A, Lopez-Pestana A, Tuneu A, Lobo C, Lopez-Nunez M, Ormaechea N. Letter: photodistributed reticulated hyperpigmentation related to diltiazem. Dermatol Online J. 2011;17(7):14.PubMed Jaka A, Lopez-Pestana A, Tuneu A, Lobo C, Lopez-Nunez M, Ormaechea N. Letter: photodistributed reticulated hyperpigmentation related to diltiazem. Dermatol Online J. 2011;17(7):14.PubMed
2.
go back to reference Kubo Y, Fukumoto D, Ishigami T, Hida Y, Arase S. Diltiazem-associated photodistributed hyperpigmentation: report of two Japanese cases and published work review. J Dermatol. 2010;37:807–11.PubMedCrossRef Kubo Y, Fukumoto D, Ishigami T, Hida Y, Arase S. Diltiazem-associated photodistributed hyperpigmentation: report of two Japanese cases and published work review. J Dermatol. 2010;37:807–11.PubMedCrossRef
3.
go back to reference Desai N, Alexis A, DeLeo V. Facial hyperpigmentation caused by diltiazem hydrochloride. Cutis. 2010;86(2):82–4.PubMed Desai N, Alexis A, DeLeo V. Facial hyperpigmentation caused by diltiazem hydrochloride. Cutis. 2010;86(2):82–4.PubMed
Metadata
Title
Diltiazem-Associated Hyperpigmentation
Authors
Michelle Campbell, MD
Jesleen Ahluwalia, MD
Alice C. Watson, MD
Publication date
01-12-2013
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2530-1

Other articles of this Issue 12/2013

Journal of General Internal Medicine 12/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine